Acromegaly clinical trials
The registry lists 196 studies for Acromegaly across more than 10 countries. 18 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-25.
Status
- Completed
- 128
- Status unknown
- 26
- Terminated
- 16
- Recruiting
- 14
- Withdrawn
- 5
- Not yet recruiting
- 4
Phase
- Phase 3
- 32
- Phase 2
- 27
- Phase 4
- 24
- Phase 1
- 11
Where
- United States
- 63
- Italy
- 45
- France
- 37
- Germany
- 34
- United Kingdom
- 31
- Poland
- 27
Who runs them
Ipsen (33) · Novartis Pharmaceuticals (15) · University of Aarhus (9) · Cedars-Sinai Medical Center (9) · Pfizer (6) · Crinetics Pharmaceuticals Inc. (5) · Federico II University (5) · Camurus AB (4)
Studies
Recruiting first, then most recently updated. Showing 50 of 196 — search for more.
- An Observational Study of Octreotide Subcutaneous Depot in Patients With AcromegalyRecruitingNCT075835632 countries
- An Investigation of Pituitary Tumors and Related Hypothalmic DisordersRecruitingNCT000015951 country
- A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin AnalogsRecruitingNCT06930625Phase 321 countries
- A Study to Evaluate MAR002 for AcromegalyRecruitingNCT07641179Phase 21 country
- PRESTO: A Phase III Randomised Controlled Trial of Dose-escalated Proton Beam Therapy Versus Standard of Care Radiotherapy for Functioning Pituitary TumoursNot yet recruitingNCT07813351Phase 3
- Direct Versus Video Laryngoscopy in Patients With AcromegalyNot yet recruitingNCT07659912
- Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPARecruitingNCT004611881 country
- Study of MAR002 in Healthy MenRecruitingNCT07195175Phase 11 country
- Ultrasound in Predicting Difficult Intubation in Acromegaly PatientsNot yet recruitingNCT073063251 country
- Effects of Pasireotide Lar Therapy on Bone MetabolismRecruitingNCT071799261 country
- Effects of Therapies in the Acromegaly Disease: Acral Morpho-functional StudyRecruitingNCT059647121 country
- KETOgenic Diet Therapy in Patients With ACROmegalyRecruitingNCT06949891Not applicable1 country
- The RApid Switch From 1st Generation Somatostatin Analogues to PaSireOtiDe In AcromegalyRecruitingNCT065973831 country
- Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess.RecruitingNCT063446501 country
- Diet in the Management of AcromegalyRecruitingNCT05401084Not applicable1 country
- Hypoproteic Diet in AcromegalyNot yet recruitingNCT05298891Not applicable1 country
- The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness ResearchRecruitingNCT031580901 country
- Developing a Simple Recognition System of AcromegalyRecruitingNCT030420261 country
- A Phase 1 Study to Evaluate the Relative Bioavailability of Octreotide Acetate Tablets(T25) Compared to MYCAPSSA® and The Food Effect on Pharmacokinetics Of Octreotide Acetate Tablets(T25)CompletedNCT07663318Phase 11 country
- A Clinical Trial to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Octreotide Long-acting Injection in Patients With AcromegalyCompletedNCT07814651Phase 21 country
- A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With AcromegalyCompletedNCT04076462Phase 310 countries
- ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With AcromegalyTerminatedNCT07037420Phase 24 countries
- A Study to Evaluate the Long-Term Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Advance)TerminatedNCT04261712Phase 27 countries
- Korean Regulatory Post Marketing Surveillance for SomavertCompletedNCT051311001 country
- A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)TerminatedNCT05192382Phase 315 countries
- A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of AcromegalyTerminatedNCT04837040Phase 314 countries
- ACRODAT Prospective Evaluation StudyCompletedNCT043498391 country
- Peri-operative Dynamics of the Growth Hormone Axis in Subjects With AcromegalyCompletedNCT009216091 country
- Long Term Outcome Study in Patients With Pituitary DisordersActive, not recruitingNCT03665064
- A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With AcromegalyCompletedNCT04125836Phase 311 countries
- Reproducibility and Utility of OGTT in AcromegalyCompletedNCT04066569Not applicable1 country
- A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)TerminatedNCT05364944Phase 18 countries
- Ketogenic vs. Mediterranean Diet on Metabolic and Hormonal Parameters in Patients With Active AcromegalyCompletedNCT07100587Not applicable1 country
- A Prospective Study of Outcome After Therapy for AcromegalyCompletedNCT018098081 country
- A Phase 1 Study of TE-8214 Solution in Healthy VolunteersCompletedNCT06372652Phase 11 country
- Treatment Patterns and Treatment Outcomes for AcromegalyCompletedNCT030435861 country
- A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve)CompletedNCT03792555Phase 28 countries
- An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge)CompletedNCT03789656Phase 212 countries
- Oral Glucose Tolerance Testing (OGTT) on Patients Taking Somatostatin AnalogsWithdrawnNCT013710451 country
- Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in ChinaCompletedNCT054318031 country
- PegvisOMant and the Immune SystEm (PROMISE)CompletedNCT050693241 country
- A Study to Understand Participant's Experiences in Gastro-enteropancreatic Neuroendocrine Tumors (GEP-NETs) and AcromegalyCompletedNCT062538971 country
- A Study to Assess the Safety, Tolerability, and Efficacy of IONIS-GHR-LRx Administered in Patients With AcromegalyCompletedNCT04522180Phase 210 countries
- Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored StudiesCompletedNCT01794793Phase 428 countries
- Acromegaly Resistant to Conventional Dose of First Generation Somatostatin LigandsCompletedNCT066076661 country
- Effects of Sandostatin LAR® in AcromegalyCompletedNCT01424241Phase 41 country
- Acromegaly: Balance, Falls and Fracture RiskCompletedNCT057528251 country
- Modulating the GIP System in Patients With Acromegaly Due to a Pituitary TumorCompletedNCT03807076Not applicable1 country
- Dynamic Hormone Diagnostics in Endocrine DiseaseCompletedNCT029343994 countries
- A Single-dose Study of Octreotide Injection in Healthy Adult SubjectsCompletedNCT05761431Phase 11 country